fda glp-1 compounding crackdown september 2025 BREAKING NEWS in the space 🚨 is at it again saying they're going to take action limiting access to the active ingredients used to make the compounded medications. Watch FDA Warns Telehealth Firms Over

Visual indicators include color change (from blue to green, brown, or cloudy), visible particles or precipitation, and unusual film or residue

By Drug Type: Prescription Dominance Reinforced by Payer Mandates Prescription products represented 64.53% of the anti-obesity drugs market in 2025, and the cohort is on track for a 32.85% CAGR through 2031

Swirl gently: Let the powder fully dissolve

Summary of Storage Timelines Key Takeaway: While all GLP-1 injectables prefer the refrigerator, they all have a safe window at room temperature

Due to the complexity of both ASD and sensory-based approaches, the research base for these approaches is limited